UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Suppression of c‐Myc using 10058‐F4 exerts caspase‐3‐dependent apoptosis and intensifies the antileukemic effect of vincristine in pre‐B acute lymphoblastic leukemia cells

Journal of cellular biochemistry, 2019-08, Vol.120 (8), p.14004-14016

2019

Volltextzugriff (PDF)

The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma: Possibilities for therapeutic interventions either as single agents or in combination with conventional therapies

IUBMB life, 2021-04, Vol.73 (4), p.618-642

2021

Volltextzugriff (PDF)

Anti‐leukemic effect of PI3K inhibition on chronic myeloid leukemia (CML) cells: shedding new light on the mitigating effect of c‐Myc and autophagy on BKM120 cytotoxicity

Cell biology international, 2020-05, Vol.44 (5), p.1212-1223

2020

Volltextzugriff (PDF)

The PI3K/Akt signaling axis in Alzheimer’s disease: a valuable target to stimulate or suppress?

Cell stress & chaperones, 2021-11, Vol.26 (6), p.871-887

2021

Volltextzugriff (PDF)

Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status

The international journal of biochemistry & cell biology, 2019-03, Vol.108, p.7-16

2019

Volltextzugriff (PDF)

Melatonin, an inhibitory agent in breast cancer

Breast cancer (Tokyo, Japan), 2017, Vol.24 (1), p.42-51

2017

Volltextzugriff (PDF)

PI3K Abrogation Using Pan-PI3K Inhibitor BKM120 Gives Rise to a Significant Anticancer Effect on AML-Derived KG-1 Cells by Inducing Apoptosis and G2/M Arrest

Turkish journal of haematology, 2020-01, Vol.37 (3), p.167-176

2020

Volltextzugriff (PDF)

C-Myc inhibition sensitizes pre-B ALL cells to the anti-tumor effect of vincristine by altering apoptosis and autophagy: Proposing a probable mechanism of action for 10058-F4

European journal of pharmacology, 2020-03, Vol.870, p.172821-172821, Article 172821

2020

Volltextzugriff (PDF)

ZnO/CNT@Fe3O4 induces ROS-mediated apoptosis in chronic myeloid leukemia (CML) cells: an emerging prospective for nanoparticles in leukemia treatment

Artificial cells, nanomedicine, and biotechnology, 2020-01, Vol.48 (1), p.735-745

2020

Volltextzugriff (PDF)

Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCR

BMC urology, 2021-04, Vol.21 (1), p.64-64, Article 64

2021

Volltextzugriff (PDF)

Apoptin Overexpression Efficiently Amplified Cytotoxic Effects of PI3K Inhibition Using BKM120 in Lymphoblastic Leukemia Cell Lines

Advanced pharmaceutical bulletin, 2022-05, Vol.12 (3), p.613-622

2022

Volltextzugriff (PDF)

Suppression of proteasome induces apoptosis in APL cells and increases chemo-sensitivity to arsenic trioxide: Proposing a perception in APL treatment

Cancer treatment and research communications, 2021, Vol.26, p.100284-100284, Article 100284

2021

Volltextzugriff (PDF)

Pan-HDAC inhibitor panobinostat, as a single agent or in combination with PI3K inhibitor, induces apoptosis in APL cells: An emerging approach to overcome MSC-induced resistance

The international journal of biochemistry & cell biology, 2020-05, Vol.122, p.105734-105734, Article 105734

2020

Volltextzugriff (PDF)

Stimulatory Effect of Indolic Hormone on As2O3 Cytotoxicity in Breast Cancer Cells: NF-κB-dependent Mechanism of Action of Melatonin

International journal of molecular and cellular medicine, 2018-01, Vol.7 (3), p.158-168

2018

Volltextzugriff (PDF)

Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy

European journal of pharmacology, 2023-08, Vol.953, p.175827-175827, Article 175827

2023

Volltextzugriff (PDF)

The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19

International immunopharmacology, 2021-06, Vol.95, p.107586-107586, Article 107586

2021

Volltextzugriff (PDF)

Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity

International immunopharmacology, 2021-10, Vol.99, p.107995-107995, Article 107995

2021

Volltextzugriff (PDF)

The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions

European journal of pharmacology, 2021-05, Vol.898, p.173983-173983, Article 173983

2021

Volltextzugriff (PDF)

Kinase inhibitors: Opportunities for small molecule anticancer immunotherapies

Drug discovery today, 2023-05, Vol.28 (5), p.103525-103525, Article 103525

2023

Volltextzugriff (PDF)

Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO)

The international journal of biochemistry & cell biology, 2019-11, Vol.116, p.105615-105615, Article 105615

2019

Volltextzugriff (PDF)

Anticancer effect of pan-PI3K inhibitor on multiple myeloma cells: Shedding new light on the mechanisms involved in BKM120 resistance

European journal of pharmacology, 2019-01, Vol.842, p.89-98

2019

Volltextzugriff (PDF)

Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity

European journal of pharmacology, 2020-05, Vol.875, p.173050, Article 173050

2020

Volltextzugriff (PDF)

Activation of PPARγ intensified the effects of arsenic trioxide in acute promyelocytic leukemia through the suppression of PI3K/Akt pathway: Proposing a novel anticancer effect for pioglitazone

The international journal of biochemistry & cell biology, 2020-05, Vol.122, p.105739-105739, Article 105739

2020

Volltextzugriff (PDF)

c-Myc Inhibition Using 10058-F4 Increased the Sensitivity of Acute Promyelocytic Leukemia Cells to Arsenic Trioxide Via Blunting PI3K/NF-κB Axis

Archives of medical research, 2020-10, Vol.51 (7), p.636-644

2020

Volltextzugriff (PDF)

Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120

European journal of pharmacology, 2018-12, Vol.841, p.10-18

2018

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Humans
(27)
Pharmacology & Pharmacy
(16)
Apoptosis - Drug Effects
(14)
Antineoplastic Agents - Pharmacology
(12)
Apoptosis
(12)
Cell Biology
(12)
Cell Line, Tumor
(11)
Arsenic Trioxide
(10)
Autophagy
(10)
Biochemistry & Molecular Biology
(10)
C-Myc
(10)
Cell Proliferation - Drug Effects
(10)
Drug Synergism
(10)
Cell Survival - Drug Effects
(8)
Morpholines - Pharmacology
(8)
Aminopyridines - Pharmacology
(7)
Bkm120
(7)
Nf-Κb
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Suppression of c‐Myc using 10058‐F4 exerts caspase‐3‐dependent apoptosis and intensifies the antileukemic effect of vincristine in pre‐B acute lymphoblastic leukemia cells

The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma: Possibilities for therapeutic interventions either as single agents or in combination with conventional therapies

Anti‐leukemic effect of PI3K inhibition on chronic myeloid leukemia (CML) cells: shedding new light on the mitigating effect of c‐Myc and autophagy on BKM120 cytotoxicity

The PI3K/Akt signaling axis in Alzheimer’s disease: a valuable target to stimulate or suppress?

Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status

Melatonin, an inhibitory agent in breast cancer

PI3K Abrogation Using Pan-PI3K Inhibitor BKM120 Gives Rise to a Significant Anticancer Effect on AML-Derived KG-1 Cells by Inducing Apoptosis and G2/M Arrest

C-Myc inhibition sensitizes pre-B ALL cells to the anti-tumor effect of vincristine by altering apoptosis and autophagy: Proposing a probable mechanism of action for 10058-F4

ZnO/CNT@Fe3O4 induces ROS-mediated apoptosis in chronic myeloid leukemia (CML) cells: an emerging prospective for nanoparticles in leukemia treatment

Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCR

Apoptin Overexpression Efficiently Amplified Cytotoxic Effects of PI3K Inhibition Using BKM120 in Lymphoblastic Leukemia Cell Lines

Suppression of proteasome induces apoptosis in APL cells and increases chemo-sensitivity to arsenic trioxide: Proposing a perception in APL treatment

Pan-HDAC inhibitor panobinostat, as a single agent or in combination with PI3K inhibitor, induces apoptosis in APL cells: An emerging approach to overcome MSC-induced resistance

Stimulatory Effect of Indolic Hormone on As2O3 Cytotoxicity in Breast Cancer Cells: NF-κB-dependent Mechanism of Action of Melatonin

Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy

The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19

Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity

The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions

Kinase inhibitors: Opportunities for small molecule anticancer immunotherapies

Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO)

Anticancer effect of pan-PI3K inhibitor on multiple myeloma cells: Shedding new light on the mechanisms involved in BKM120 resistance

Anti-leukemic effects of histone deacetylase (HDAC) inhibition in acute lymphoblastic leukemia (ALL) cells: Shedding light on mitigating effects of NF-κB and autophagy on panobinostat cytotoxicity

Activation of PPARγ intensified the effects of arsenic trioxide in acute promyelocytic leukemia through the suppression of PI3K/Akt pathway: Proposing a novel anticancer effect for pioglitazone

c-Myc Inhibition Using 10058-F4 Increased the Sensitivity of Acute Promyelocytic Leukemia Cells to Arsenic Trioxide Via Blunting PI3K/NF-κB Axis

Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120

Suchergebnisse filtern